Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,883 total articles

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
May 11, 2026
Nina Shah
Press Releases

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix, Inc. announced presentations at the American Thoracic Society 2026 Annual Meeting showcasing real-world clinical data and healthcare system economic value of its Nodify Lung® blood-based testing for lung nodule risk stratification. The data highlights improvements in lung cancer detection and patient outcomes, supported by academic and co…

BDSX
RenX Enterprises Corp. Issues Letter to Shareholders
May 11, 2026
Nina Shah
Press Releases

RenX Enterprises Corp. Issues Letter to Shareholders

RenX Enterprises Corp. outlines strategic progress including integration of Resource Group US Holdings and upgrades to its biomass recycling operations. With growing geopolitical disruption causing input price inflation and import dependencies in agriculture, RenX positions its locally sourced, engineered soils as a strategic alternative. The compa…

RENX
WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model
May 11, 2026
Sofia Navarro
Press Releases

WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model

WORK Medical Technology Group LTD announced a strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to jointly develop AI-driven intelligent medical models focused on protein antibody therapeutics. The collaboration includes four major AI+ projects targeting biomolecular design and functional simulation. They aim to crea…

WOK
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101
May 11, 2026
Sofia Navarro
Press Releases

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Ernexa Therapeutics released a Virtual Investor KOL Connect segment featuring insights from its Chief Scientific Officer on the complexities of ovarian cancer and the potential for their lead cell therapy candidate ERNA-101 to address existing treatment limitations. The company also announced participation in an upcoming Virtual Investor Closing Be…

ERNA
The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™
May 11, 2026
Ajmal Hussain
Press Releases

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™

The Boston Beer Company introduces LYTT® Electric Coolers, a new line of single-serve, 15% alcohol-by-volume ready-to-drink beverages packaged in patent-pending, glow-in-the-dark lightbulb-shaped containers. Launching in select U.S. markets in mid-2026, this product aims to capture a share of the growing high-alcohol ready-to-drink market with recy…

SAM
Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)
May 11, 2026
Derek Hwang
Press Releases

Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)

Longeveron Inc. announced that the independent Data Monitoring Committee (DMC) conducted a final safety review of the fully enrolled Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as adjunct therapy for Hypoplastic Left Heart Syndrome (HLHS). The DMC found no new safety concerns, approved continuation to completion, and top-line result…

LGVN
HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss
May 11, 2026
Jordan Park
Press Releases

HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

PacBio announced the first major study from the HiFi Solves Sub-fertility Consortium in Asia Pacific, showcasing the use of their HiFi long-read whole genome sequencing to analyze unexplained subfertility and recurrent pregnancy loss across multiple institutions. The study demonstrated that HiFi sequencing can provide a comprehensive genetic view i…

PACB
Brookfield to Invest $500 Million in Strategic Partnership with OpenAI
May 11, 2026
Marcus Reed
Press Releases

Brookfield to Invest $500 Million in Strategic Partnership with OpenAI

Brookfield Asset Management has agreed to invest $500 million in The OpenAI Deployment Company, a joint venture with OpenAI and other investors aimed at accelerating large-scale enterprise AI deployment. Brookfield sees this partnership as a key growth driver to leverage AI technologies across its global portfolio, focusing on improving productivit…

BAM
Telos Corporation Announces First Quarter 2026 Earnings
May 11, 2026
Ajmal Hussain
Press Releases

Telos Corporation Announces First Quarter 2026 Earnings

Telos Corporation, a leading provider of cybersecurity and enterprise security solutions, has posted its financial results for the first quarter of 2026 and scheduled a live webcast to discuss the results. The company serves the U.S. federal government and global enterprises with advanced cyber governance, identity, biometric, and secure communicat…

TLS
Airship AI Reports First Quarter 2026 Financial Results
May 11, 2026
Derek Hwang
Press Releases

Airship AI Reports First Quarter 2026 Financial Results

Airship AI Holdings, Inc. announced its Q1 2026 financial results showing a 15% increase in net revenues to $6.3 million and a gross margin of 50%, driven by increased sales of proprietary hardware and software. Despite a net loss of $721,000 impacted by stock-based compensation and noncash expenses, the company maintained positive operating cash f…

AISP
Interlink Electronics, Inc. Announces Execution of Non-Binding Letter of Intent For Potential Strategic Acquisition
May 11, 2026
Jordan Park
Press Releases

Interlink Electronics, Inc. Announces Execution of Non-Binding Letter of Intent For Potential Strategic Acquisition

Interlink Electronics, Inc. has executed a non-binding letter of intent to acquire a company specializing in high-performance manufacturing solutions for mission-critical markets such as semiconductor, defense, laser and photonics, commercial high-tech, and aerospace. The acquisition aims to bolster Interlink's technological capabilities and market…

LINK
Mobilicom Launches SkyHopper Tactical, Advancing Tactical Drone and Autonomous Operations Capabilities
May 11, 2026
Derek Hwang
Press Releases

Mobilicom Launches SkyHopper Tactical, Advancing Tactical Drone and Autonomous Operations Capabilities

Mobilicom Limited announced the launch of SkyHopper Tactical, a wearable software-defined radio designed to expand their tactical communications portfolio supporting autonomous systems and drones. The platform, developed based on U.S. Department of War requirements, supports multi-operator and swarm operations in GPS-denied and contested environmen…

MOB
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
May 11, 2026
Jordan Park
Press Releases

Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®

Abeona Therapeutics announced that the Children's Hospital of Philadelphia has been activated as its sixth Qualified Treatment Center for ZEVASKYN, the first autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB). This expansion enhances patient access on the East Coast and signifies progress in delivering advanced…

ABEO
Streamex Corp. Provides May 2026 Shareholder Update
May 11, 2026
Hana Yamamoto
Press Releases

Streamex Corp. Provides May 2026 Shareholder Update

Streamex Corp. provides a detailed shareholder update highlighting their progress in developing a scalable platform for tokenized commodity assets, including their first product GLDY which tracks gold. The company outlines addressing operational challenges, expanding distribution and liquidity infrastructure, and plans to introduce additional commo…

STEX